bluebird bio Inc (BLUE)
1.02
+0.07
(+7.03%)
USD |
NASDAQ |
Apr 19, 15:55
bluebird bio Enterprise Value: 9.39M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 9.39M |
| April 17, 2024 | 11.38M |
| April 16, 2024 | 16.58M |
| April 15, 2024 | 24.23M |
| April 12, 2024 | 37.72M |
| April 11, 2024 | 49.29M |
| April 10, 2024 | 55.07M |
| April 09, 2024 | 68.56M |
| April 08, 2024 | 49.29M |
| April 05, 2024 | 62.78M |
| April 04, 2024 | 62.78M |
| April 03, 2024 | 53.14M |
| April 02, 2024 | 58.92M |
| April 01, 2024 | 64.71M |
| March 28, 2024 | 72.42M |
| March 27, 2024 | 88.80M |
| March 26, 2024 | 57.00M |
| March 25, 2024 | 87.84M |
| March 22, 2024 | 89.76M |
| March 21, 2024 | 107.11M |
| March 20, 2024 | 95.55M |
| March 19, 2024 | 95.55M |
| March 18, 2024 | 103.26M |
| March 15, 2024 | 99.40M |
| March 14, 2024 | 82.05M |
| Date | Value |
|---|---|
| March 13, 2024 | 93.62M |
| March 12, 2024 | 84.94M |
| March 11, 2024 | 93.62M |
| March 08, 2024 | 114.82M |
| March 07, 2024 | 105.18M |
| March 06, 2024 | 105.18M |
| March 05, 2024 | 93.62M |
| March 04, 2024 | 120.60M |
| March 01, 2024 | 127.35M |
| February 29, 2024 | 93.62M |
| February 28, 2024 | 149.51M |
| February 27, 2024 | 163.01M |
| February 26, 2024 | 107.11M |
| February 23, 2024 | 66.63M |
| February 22, 2024 | 53.14M |
| February 21, 2024 | 35.80M |
| February 20, 2024 | 37.72M |
| February 16, 2024 | 22.30M |
| February 15, 2024 | 33.87M |
| February 14, 2024 | 23.27M |
| February 13, 2024 | 15.10M |
| February 12, 2024 | 35.80M |
| February 09, 2024 | 24.23M |
| February 08, 2024 | 28.09M |
| February 07, 2024 | 6.056M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-292.21M
Minimum
Nov 08 2021
2.717B
Maximum
May 06 2019
484.93M
Average
244.24M
Median
Feb 24 2023
Enterprise Value Benchmarks
| Agenus Inc | 52.85M |
| Motus GI Holdings Inc | -2.321M |
| Tivic Health Systems Inc | -1.69M |
| Vertex Pharmaceuticals Inc | 90.42B |
| AIM ImmunoTech Inc | 11.42M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -71.73M |
| Revenue (Quarterly) | 12.39M |
| Total Expenses (Quarterly) | 97.12M |
| EPS Diluted (Quarterly) | -0.66 |
| Gross Profit Margin (Quarterly) | 11.60% |
| Profit Margin (Quarterly) | -578.8% |
| Earnings Yield | -72.55% |
| Normalized Earnings Yield | -72.55 |